Literature DB >> 9060045

Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.

D L Horn1, S M Opal, E Lomastro.   

Abstract

Compelling experimental evidence now exists that antimicrobial agents induce the release of endotoxin from Gram-negative bacteria during the process of bacteriolysis. Different antimicrobial classes, particularly those which act upon the outer membrane of bacteria, vary in the amount of free endotoxin released from Gram-negative organisms. Despite this in vitro evidence, clinically important consequences of antibiotic-induced endotoxin release have yet to be consistently documented. Complexities in the host-pathogen interactions during actual infection with Gram-negative bacteria may account for the difficulties in demonstrating this phenomena in vivo. This brief review analyses these interactions and defines clinical settings where antibiotic-induced endotoxin release may prove to be clinically relevant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9060045

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  6 in total

1.  Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan.

Authors:  J Soltys; M T Quinn
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 2.  Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.

Authors:  S M Opal; R L Yu
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

3.  Differential tumor necrosis factor alpha expression and release from peritoneal mouse macrophages in vitro in response to proliferating gram-positive versus gram-negative bacteria.

Authors:  W Cui; D C Morrison; R Silverstein
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.

Authors:  R Silverstein; J G Wood; Q Xue; M Norimatsu; D L Horn; D C Morrison
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Drotrecogin alfa (activated).

Authors:  Katherine A Lyseng-Williamson; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Multi-drug strategies are necessary to inhibit the synergistic mechanism causing tissue damage and organ failure in post infectious sequelae.

Authors:  I Ginsburg
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 5.093

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.